A team of scientists, led by Duke-NUS Medical School, has discovered a potential intranasal vaccine candidate that provides improved, longer-lasting immunity against SARS-CoV-2 viruses compared to when given as an injection.
New intranasal vaccine candidate triggers powerful mucosal defense against SARS-CoV-2
- Post author:
- Post published:January 10, 2024
- Post category:uncategorized